Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc (SPRO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $71.6M; returns 1 day -1.8%, 1 week +0.9%, 1 year -49.5%.

Spero Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases.

Groups SPRO belongs to

• Biotechnology
• Clinical Stage Biotech
• Gram-Negative Bacteria
• Healthcare
• Biopharmaceutical
• Infectious Diseases
• Pharmaceuticals
• Life Sciences
• Rare Diseases
• Strategic Partnerships

SPRO financial model: income statement, cash flow and balance sheet